- Ticker
- ABIO
- Price
- 3.26
- Stock movement down
- -0.03 (-0.76%)
- Company name
- ARCA Biopharma Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 47.29M
- Ent value
- 12.97M
- Price/Sales
- 268.71
- Price/Book
- 1.35
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -48.58%
- 1 year return
- 60.59%
- 3 year return
- 4.22%
- 5 year return
- -13.98%
- 10 year return
- -33.10%
Last updated: 2024-07-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ABIO does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 268.71 |
| Price to Book | 1.35 |
| EV to Sales | 73.70 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 14.51M |
| EPS (TTM) | -0.38 |
| FCF per share (TTM) | -0.34 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 176.00K |
| Gross profit (TTM) | 75.00K |
| Operating income (TTM) | -7.98M |
| Net income (TTM) | -5.48M |
| EPS (TTM) | -0.38 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 42.61% |
| Operating margin (TTM) | -4535.23% |
| Profit margin (TTM) | -3113.64% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 35.90M |
| Net receivables | 0.00 |
| Total current assets | 36.67M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 239.00K |
| Total assets | 36.71M |
| Accounts payable | 529.00K |
| Short/Current long term debt | 48.00K |
| Total current liabilities | 1.58M |
| Total liabilities | 1.58M |
| Shareholder's equity | 35.13M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -4.95M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -4.95M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -15.60% |
| Return on Assets | -14.93% |
| Return on Invested Capital | -15.58% |
| Cash Return on Invested Capital | -14.06% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 3.22 |
| Daily high | 3.39 |
| Daily low | 3.21 |
| Daily Volume | 24K |
| All-time high | 5726700.00 |
| 1y analyst estimate | 7.00 |
| Beta | 0.96 |
| EPS (TTM) | -0.38 |
| Dividend per share | - |
| Ex-div date | 1 May 2006 |
| Next earnings date | 16 Oct 2024 |
Downside potential
Loading...
Downside potential data
| ABIO | S&P500 | |
| Current price drop from All-time high | -100.00% | -1.81% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 2 Apr 2024 | 9 Mar 2009 |
| Avg drop from high | -94.19% | -11.26% |
| Avg time to new high | 295 days | 12 days |
| Max time to new high | 6143 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
47.29M
Marketcap category
Small-cap
Description
ARCA biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with heart failure. It is developing Recombinant Nematode Anticoagulant Protein c2, a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. The company has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.
Employees
4
Website
Investor relations
-
SEC filings
CEO
Michael R. Bristow
Country
USA
City
Westminster
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page